86 patents currently held
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
62 more records may belong here and await a decision; they are not counted.
The next term ends in Jan 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
52
Ending by 2030
Jan 2027
Next term end
78
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2028 · High confidence
Also notable
Ends no later than Feb 2029 · Low confidence
Also notable
Ends May 2032 · High confidence
Locator and Closure Device and Method of Use
US 8,088,144
Cited by 194 later US patents, top 5% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Flexible Stent
US 7,803,180
Cited by 84 later US patents, top 10% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
System and Method for Re-Entering a Vessel Lumen
US 8,920,449
Cited by 40 later US patents, top 25% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2032.
Formerly held, still cited
Notable
Ends Mar 2027 · High confidence
Cited by 185 later US patents, top 5% of utility patents granted in 2006 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
now held by Codman & Shurtleff, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 23, 2026The maintenance fee for Stent Delivery Catheter System with a Helicoid Hypotube (US 11,654,038) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
- 3 fees due Jan 2 to 23, 2027 · next Jan 2
- 1 fee due Feb 4, 2027The maintenance fee for System and Method for Dilating and Adjusting Flexibility in a Guiding Device (US 9,095,370) comes due Feb 4, 2027. Unpaid by Aug 4, 2027, it lapses early.
- 1 fee due Mar 19, 2027The maintenance fee for Large Lumen Guide Catheter (US 11,759,604) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
- 1 fee due Apr 6, 2027The maintenance fee for Reconstrainable Stent Delivery System (US 9,149,376) comes due Apr 6, 2027. Unpaid by Oct 6, 2027, it lapses early.
- 2 fees due Aug 9, 2027
- 3 fees due Sep 15 to 24, 2027 · next Sep 15
- 1 fee due Nov 3, 2027The maintenance fee for Driving Method of Field Sequential Display (US 9,330,620) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
- 7 terms have ended since Aug 20, 2026
What they patent
The 5 largest of its 78 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Rotary Debulking Atherectomy Device with a Crossing Balloon | 2 in force | to May 2039 |
| Large Lumen Guide Catheter | 2 in force | to Jul 2036 |
| Method and Device for Sheathless Arterial Catheterization | 2 in force | to May 2036 |
| System and Method for Dilating and Adjusting Flexibility in a Guiding Device | 2 in force | to Jan 2033 |
| Reconstrainable Stent Delivery System | 2 in force | to Jul 2032 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,399,314 | Systems and Methods for Securing Graft Material to Intraluminal Devices In force · High confidence | In force | High confidence | |
| US 8,357,194 | Stent Graft Device In force · High confidence | In force | High confidence | |
| US 7,927,676 | Plasma-Treated Vascular Occlusion Devices and Methods held by Cordis Neurovascular, Inc. and Codman & Shurtleff, Inc. In force · High confidence | In force | High confidence | |
| US 7,780,714 | Implant Delivery Apparatus In force · High confidence | In force | High confidence | |
| US 7,803,131 | Devices and Methods for Percutaneously Treating Aortic Valve Stenosis In force · High confidence | In force | High confidence | |
| US 7,785,615 | Biodegradable Medical Implant with Encapsulated Buffering Agent In force · High confidence | In force | High confidence | |
| US 7,785,317 | Joined Metal Tubing and Method of Manufacture held by Cordis Neurovascular, Inc. and Codman & Shurtleff, Inc. In force · High confidence | In force | High confidence | |
| US 8,163,006 | Reduced Profile Aaa Device In force · High confidence | In force | High confidence | |
| US 8,945,179 | Single Disc Occlusionary Patent Foramen Ovale Closure Device In force · High confidence | In force | High confidence | |
| US 7,794,487 | Reduced Deployment Force Delivery Device In force · High confidence | In force | High confidence |
Also on record, not counted in the 86: 10 patents in force now held by others · 372 patents ended · 2 applications pending · 341 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.